Carson City HHS will offer Moderna vaccine in place of one-dose Janssen


Photo: Adobe Stock

  • Discuss Comment, Blog about
  • Print Friendly and PDF
Tuesday, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention recommended a pause in the use of the single-dose Janssen (Johnson and Johnson) vaccine.
Carson City Health and Human Services will pause the use of the Janssen vaccine until the review is complete, according to a news release.
To prevent the disruption in vaccination events, CCHHS will be contacting those who have an appointment at a CCHHS Janssen event and offering them the Moderna vaccine instead. If an individual does not wish to receive the Moderna vaccine, they will need to schedule another appointment; CCHHS will not be rescheduling appointments.
To cancel appointments or to reschedule, log into your appointment account at https://booking.appointy.com/en-US/quadcovidvaccine/bookings/service.
CCHHS is urging the community to trust the safety and effectiveness of the authorized vaccines. The CDC and the Advisory Committee on Immunization Practices are meeting to review the Janssen vaccine reactions and will provide information once it is available. CCHHS will continue to work with the Nevada Department of Health and Human Services and the Nevada State Immunization Program throughout the pause and will provide additional information as it becomes available.
People who have received the Janssen vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html.
For questions, contact the Quad-County COVID-19 Hotline at 775-434-1988.
More information on the pause of the Janssen vaccine can be found at https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment